{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:32:30Z","timestamp":1787002350473,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/mt.2016.127","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T08:25:15Z","timestamp":1470126315000},"page":"1848-1859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice"],"prefix":"10.1016","volume":"24","author":[{"given":"Yoshinari","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Yoshizato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.127_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2016.127_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1038\/mt.2016.127_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/egh.11.92","article-title":"Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques","volume":"6","author":"Tacke","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1038\/mt.2016.127_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000101322","article-title":"Liver fibrosis: possible involvement of EMT","volume":"185","author":"Ikegami","year":"2007","journal-title":"Cells Tissues Organs"},{"key":"10.1038\/mt.2016.127_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2016.127_bib6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.127_bib7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1111444","article-title":"Ribo-gnome: the big world of small RNAs","volume":"309","author":"Zamore","year":"2005","journal-title":"Science"},{"key":"10.1038\/mt.2016.127_bib8","doi-asserted-by":"crossref","first-page":"e16081","DOI":"10.1371\/journal.pone.0016081","article-title":"The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families","volume":"6","author":"Murakami","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.127_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1053\/j.gastro.2012.04.007","article-title":"MicroRNAs in liver disease","volume":"142","author":"Wang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2016.127_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1038\/mt.2016.127_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2016.127_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"10.1038\/mt.2016.127_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2011.07.041","article-title":"Suppression of hepatic stellate cell activation by microRNA-29b","volume":"412","author":"Sekiya","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2016.127_bib14","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jir186","article-title":"Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture","volume":"203","author":"Bandyopadhyay","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2016.127_bib15","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2016.127_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"Lancet"},{"key":"10.1038\/mt.2016.127_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12072-014-9568-y","article-title":"Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma","volume":"8","author":"Sun","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1038\/mt.2016.127_bib18","doi-asserted-by":"crossref","first-page":"e1002147","DOI":"10.1371\/journal.pgen.1002147","article-title":"Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models","volume":"7","author":"Lai","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1038\/mt.2016.127_bib19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/labinvest.2012.70","article-title":"Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29","volume":"92","author":"Kwiecinski","year":"2012","journal-title":"Lab Invest"},{"key":"10.1038\/mt.2016.127_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nature07774","article-title":"Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation","volume":"458","author":"Aouadi","year":"2009","journal-title":"Nature"},{"key":"10.1038\/mt.2016.127_bib21","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)62495-9","article-title":"Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts","volume":"166","author":"Lee","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2016.127_bib22","doi-asserted-by":"crossref","first-page":"29290","DOI":"10.1074\/jbc.M112.394551","article-title":"Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation","volume":"287","author":"Pescatore","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2016.127_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jcb.20138","article-title":"Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells","volume":"93","author":"Mehrotra","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1038\/mt.2016.127_bib24","doi-asserted-by":"crossref","first-page":"29819","DOI":"10.1074\/jbc.C300182200","article-title":"Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras","volume":"278","author":"Dumaz","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2016.127_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature02382","article-title":"Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression","volume":"428","author":"Wang","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2016.127_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-016-5022-1","article-title":"MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma","author":"Feng","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1038\/mt.2016.127_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1158\/1078-0432.CCR-10-0331","article-title":"ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth","volume":"17","author":"Liu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2016.127_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","article-title":"Primer: inflammasomes and interleukin 1beta in inflammatory disorders","volume":"4","author":"Church","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1038\/mt.2016.127_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis\u2014a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2016.127_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/modpathol.3800711","article-title":"Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma","volume":"20","author":"Chua","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/mt.2016.127_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/bbrc.1995.1340","article-title":"Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2","volume":"208","author":"Fujimura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2016.127_bib32","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1093\/nar\/gnh093","article-title":"Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo","volume":"32","author":"Minakuchi","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2016.127_bib33","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1038\/mt.2016.127_bib34","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1073\/pnas.1202464109","article-title":"Protection from liver fibrosis by a peroxisome proliferator-activated receptor \u03b4 agonist","volume":"109","author":"Iwaisako","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.127_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/hepr.12165","article-title":"Effects of oral intake of hydrogen water on liver fibrogenesis in mice","volume":"44","author":"Koyama","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1038\/mt.2016.127_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/mt.2009.207","article-title":"Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes","volume":"18","author":"Takeshita","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.127_bib37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajpath.2014.12.017","article-title":"Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway","volume":"185","author":"Thuy","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2016.127_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:51:33Z","timestamp":1761501093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616454122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1525001616454122"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.127","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2016.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}